1.	Phase III Randomized Study of Intermittent Versus Continuous Cyproterone Acetate in Patients With Newly Diagnosed Stage III or IV Prostate Cancer Phase: Phase III Type: Treatment Status: Active Age: Under 80 Sponsor: Other Protocol IDs: SEUG-9901, BARTS-SEUK-9901, MREC-04/5/006, BARTS-P/02/203, EU-20630, NCT00363285
2.	Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11D.243, 2011-32, NCT01420250
3.	The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer Phase: No phase specified Type: Treatment Status: Active Age: 45 to 85 Sponsor: Other Protocol IDs: RAC# 2081-064, NCT01311037
4.	Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin Phase: No phase specified Type: Biomarker/Laboratory analysis, Natural history/Epidemiology Status: Active Age: 21 to 45 Sponsor: Other Protocol IDs: 11357, NCT01403688